Accedi
Accedi
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrati
Oppure accedi con
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Home
  2. Azioni
  3. Danimarca
  4. Nasdaq Copenhagen
  5. Novo Nordisk A/S
  6. Notizie
  7. Altre lingue
    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Rapporto
Tempo differito Nasdaq Copenhagen  -  16:59:43 26/05/2023
1137.60 DKK   +1.48%
26/05NOVO NORDISK: UBS ancora valutazione negativa
MD
26/05La terapia con ormone della crescita di Novo Nordisk ottiene l'approvazione dell'Agenzia Sanitaria Europea per l'uso nei bambini e negli adolescenti
MT
24/05Novo Nordisk, Life Edit Therapeutics collaborano per scoprire terapie di editing genico per malattie rare e cardiometaboliche
MT
RiassuntoQuotazioniGraficiNotizieRatingCalendarioSocietąFinanzaConsensusRevisioniDerivatiFondi 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settoreAnalisi MarketScreener
Notizie in altre lingue su NOVO NORDISK A/S
26/05Europe : bourses apathiques avant l'inflation US
26/05Novo Nordisk : avis positif du CHMP pour Sogroya
26/05Novo Nordisk's Growth Hormone Therapy Wins EU Health Agency Backing for Use in Children..
26/05Engpass bei Novo-Nordisk-Diabetesmittel durch Off-Label-Nutzung als Abnehmhilfe
24/05Novo Nordisk, Life Edit Therapeutics Collaborate to Discover Gene Editing Therapies for..
24/05Novo Nordisk Teams Up with ElevateBio Unit to Develop Gene Editing Therapies
24/05Novo Nordisk : accord de R&D avec Life Edit Therapeutics
24/05Novo Nordisk, Life Edit Therapeutics in Gene-Editing Collaboration
24/05Novo Nordisk and Life Edit Therapeutics establish multi-target collaboration to discove..
24/05Novo Nordisk : Stifel maintient sa note sur le titre
24/05Eli-Lilly-Chef hofft auf Kassenschlager bei neuen Medikamenten
24/05ElevateBio, LLC announced that it has received $401 million in funding from a group of ..
23/05Global markets live: Micron, Qantas, Zoom, Meta, BT Group...
23/05Pathos Obtains Worldwide Rights From Novo Nordisk for the Development of CBP/p300 Inhib..
23/05Novo Nordisk A/S, Oral semaglutide 50 mg achieved 15.1% weight loss in adults with obes..
23/05Novo Nordisk : Oddo BHF maintient sa recommandation
23/05Novo Nordisk : résultats prometteurs pour le semaglitude
23/05EN DIRECTO DESDE LOS MERCADOS: JPMorgan, Inditex, Micron, ..
23/05Bolsa de Madrid: Los plumíferos se mueven
23/05Les emplafonnés s'activent
23/05En Direct des Marchés : Société Générale, Faurecia, Casino, Bondue..
23/05Weight-loss drug pioneers aim to jump on Wegovy bandwagon
22/05Health Care Up Slightly as Pfizer Rallies on Weight-Drug Hopes -- Health Care Roundup
22/05Novo Nordisk Says Phase 3a Trial of Once-Daily Oral Semaglutide 50 Milligram Meets Prim..
22/05Equity Markets Struggle for Direction With Debt Ceiling Discussions in Focus
22/05Wall Street ends mixed as investors await debt ceiling talks
22/05Equity Markets Struggle for Direction With Debt Ceiling Discussions in Focus
22/05Las pastillas para adelgazar de Novo y Pfizer funcionan tan bien como la inyección
22/05Aktien New York Schluss: Kaum verändert vor Schuldenstreit-Gespr..
22/05Sector Update: Health Care Stocks Slightly Higher Late Monday
22/05Sector Update: Health Care Stocks Advancing Monday Afternoon
22/05Aktien New York: Dow schwächelt leicht - Warten auf Lösung im Schuldenst..
22/05Sector Update: Health Care
22/05Les actions freinées par la prudence sur la dette américaine
22/05Aktien Europa Schluss: Wenig verändert - Rally an Griechenlands Bö..
22/05Point marchés-Les actions freinées par la prudence sur la dette américaine
22/05Novo Nordisk says trial of oral weight-loss drug shows significant result
22/05Top Stories at Midday: Meta Hit With $1.3 Billion Fine; China Bans..
22/05Pfizer's diabetes drug results in similar weight loss levels as Novo's Ozempic
22/05Pfizer Shares Rise After Trial Reportedly Shows Danuglipron Causes as Much Weight Loss ..
22/05Shares of pfizer inc up 4.4% after diabetes drug resulted in wei…
22/05Pfizer diabetes drug reduces weight similar to Novo's Ozempic
22/05Pfizer's Weight Loss Drug Danuglipron Seen as Effective as Novo Nordisk's Ozempic; Pfiz..
22/05Novo Nordisk Reports Statistically Significant Results from Phase 3a Trial of Weight Ma..
22/05Novo Nordisk A/s: Oral semaglutide 50 mg achieved 15.1% weight loss (17.4% if all people ..
22/05Novo Nordisk A/S Announces Headline Results from OASIS 1
22/05Intercept tumbles on concerns over prospects of fatty liver disease drug
22/05Novo Nordisk A/S - share repurchase programme
22/05Les actions sur la défensive avant des discussions sur la dette américaine
22/05Intercept shares tumble on concerns over NASH drug prospects
22/05Point marchés-Les actions sur la défensive avant des discussions sur la dette américain..
22/05Aktien Europa: Träger Wochenstart
22/05European stocks muted as US debt ceiling concerns linger
22/05La preocupación por el techo de deuda de EEUU hace mella en las bolsas europeas
22/05European stocks muted as US debt ceiling concerns weigh
22/05Nanexa - Moments of truth closing in
22/05Les valeurs à suivre à Paris et en Europe (actualisé)
20/05Obesity drug brings heart health benefit alongside weight loss - study
19/05US FDA panel votes against approval of Intercept fatty liver drug, cites safety issues
19/05Catalent cuts annual revenue forecast hurt by operational challenges
19/05Novo Nordisk : Taking on board another upbeat performance
17/05Novo Holdings leads $100M Series a Financing to Advance Gene Therapies for Blinding Dis..
15/05Novo Nordisk A/s: Trading in Novo Nordisk shares by board members, executives and associa..
15/05Novo Nordisk A/S - share repurchase programme
12/05Sector Update: Health Care Stocks Easing Late Friday
12/05Sector Update: Health Care Stocks Dropping in Afternoon Trading
12/05Sector Update: Health Care
12/05Novo Nordisk, Eli Lilly's Weight-Loss Drugs Not a 'Silver Bullet' for Obesity, WHO Repo..
12/05Weight-loss drugs: the next gold rush
12/05Exclusive-Wegovy, other weight loss drugs 'no silver bullet', says WHO amid obesity rev..
10/05Insulin makers testify on Capitol Hill over prices
10/05Sen. Sanders grills Pharma CEOs on insulin prices
10/05Sen. Sanders grills Pharma CEOs on insulin prices
10/05Pharma CEOs to testify in U.S. Senate hearing on insulin prices
10/05Novo Nordisk A/s: Trading in Novo Nordisk shares by board members, executives and associa..
10/05Zealand, Boehringer's drug meets main weight-loss goal in mid-stage trial
09/05Trading in Novo Nordisk shares by board members, executives and associated persons
09/05Novo Nordisk A/S - share repurchase programme
09/05Novo Nordisk A/S purchases B shares worth DKK 3,889 million from Novo Holdings A/S unde..
09/05Novo Nordisk A/s: Trading in Novo Nordisk shares by board members, executives and associa..
09/05Komodo Health Platform Powers 17 Cutting-Edge Health Economics and Outcomes Research Pr..
09/05Los mercados bursátiles escandinavos: especificidad..
08/05Aktien Europa Schluss: Moderate Gewinne zu Wochenbeginn
08/05Les marchés boursiers scandinaves : spécificités, opér..
08/05Catalent shares tank on warning of $400 mln cut to annual revenue forecast
08/05Les actions en mouvement : Nanobiotix on fire, Samhällsbyggnads..
08/05After weight loss, Alzheimer's may be next frontier for drugs like Ozempic
08/05Aktien Europa: Stabiler Wochenstart - Ölwerte gefragt
08/05Las bolsas europeas abren sin cambios a la espera de los datos de inflación de EEUU
08/05European shares muted ahead of key U.S. inflation data
05/05Novo Nordisk : dépassé par la demande pour son anti-obésité
05/05ANALYSEN DES TAGES von Dow Jones Newswires (05.05.2023)
05/05Adipositas als Hoffnungsträger der Pharmabranche
05/05La interrupción del suministro de Wegovy de Novo Nordisk, en el punto de mira -- Market..
05/05Equity Research | Nanexa: Solid progress in development into 2023, with funding needs on ..
04/05Novo Nordisk rivals see room to compete in $100 bln weight-loss drug market
04/05Global markets live: Adecco, Qualcomm, Shell, Vodafone, Unilever...
04/05Aktien Europa Schluss: Kurse fallen nach weiterer Zinserhöhung
04/05CAC40 : la lourdeur l'emporte,la BCE veut freiner l'inflation
04/05Novo Nordisk : Good Q1, but markets have too high expectations
Prossimo evento su NOVO NORDISK A/S
-40%: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
Iscriviti
fermer